Freedom Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,146
Closed -$253K 875
2021
Q2
$253K Buy
+4,146
New +$220K 0.02% 752
2020
Q2
Sell
-7,028
Closed -$206K 637
2020
Q1
$206K Buy
7,028
+96
+1% +$2.96K 0.02% 619
2019
Q4
$249K Buy
+6,932
New +$239K 0.02% 562
2017
Q4
Sell
-13,767
Closed -$515K 1155
2017
Q3
$515K Buy
13,767
+3,792
+38% +$129K 0.03% 581
2017
Q2
$311K Buy
+9,975
New +$288K 0.02% 773

Other funds holding LMAT

Freedom Investment Management's LMAT Position: Q3 2021 in Review

Freedom Investment Management sold out of LeMaitre Vascular (LMAT) in Q3 2021, closing a stake of 4,146 shares — an estimated $253K sold.

Freedom Investment Management first reported a position in LMAT in Q2 2017 and held it in 5 quarters. The position peaked at $515K in Q3 2017. 195 funds tracked by Wall St. Rank hold LMAT as of Q3 2021.

  • Freedom Investment Management reported no remaining LeMaitre Vascular position as of Q3 2021 after selling out during the quarter.
  • Freedom Investment Management sold 4,146 LeMaitre Vascular shares in Q3 2021, an estimated $253K.
  • Freedom Investment Management first reported a position in LeMaitre Vascular in Q2 2017 and held it in 5 quarters.
  • Freedom Investment Management's LeMaitre Vascular position peaked at $515K in Q3 2017.
  • 195 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2021.

Based on Freedom Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.